Baseline disease characteristics in patients with moderate and severe rheumatoid arthritis in TEMPO. Values are mean (SD).
| Measure | MTX | ETN 25 mg | ETN + MTX | |||
|---|---|---|---|---|---|---|
| Moderate, n = 16 | Severe, n = 211 | Moderate, n = 8 | Severe, n = 214 | Moderate, n = 17 | Severe, n = 211 | |
| HAQ, 0–3 | 0.92 (0.67) | 1.77 (0.66) | 1.02 (0.64) | 1.78 (0.65) | 1.10 (0.74) | 1.81 (0.56) |
| Tender joint count, 0–28 | 9.44 (4.43) | 18.25 (6.22) | 9.13 (3.44) | 18.80 (6.32) | 8.53 (5.49) | 19.22 (6.17) |
| Swollen joint count, 0–28 | 10.0 (2.92) | 15.41 (5.54) | 7.38 (2.50) | 15.72 (5.66) | 9.24 (4.22) | 15.44 (5.78) |
| CRP, mg/l | 0.75 (0.54) | 2.73 (2.89) | 1.38 (2.66) | 3.28 (3.78) | 1.77 (2.28) | 3.0 (3.23) |
| ESR, mm/h | 10.31 (8.54) | 43.08 (25.74) | 17.25 (11.76) | 41.52 (22.68) | 14.94 (13.22) | 41.51 (24.69) |
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; ETN: etanercept; HAQ: Health Assessment Questionnaire; MTX: methotrexate.